Clinical Trial Update: PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment [NA]

View source ↗

Summary

Clinical trial update on a PSMA and TARP peptide vaccine with a Poly IC-LC adjuvant in HLA-A2 positive patients with elevated PSA after definitive treatment for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSMA and TARP peptide vaccine
• Poly IC-LC adjuvant

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2014-02-19